Literature DB >> 15183600

Urinary steroid metabolites and 11beta-hydroxysteroid dehydrogenase activity in patients with unipolar recurrent major depression.

Viktória Poór1, Susan Juricskay, Agnes Gáti, Péter Osváth, Tamás Tényi.   

Abstract

BACKGROUND: The aim of the present study was to obtain comprehensive information on steroid metabolism in depressed patients.
METHODS: 24-h urinary steroids were measured by gas chromatography in patients with unipolar recurrent major depression (URMD) compared to controls, and an index of relative activity of the 11beta-hydroxysteroid dehydrogenase (11beta-HSD) enzyme was calculated.
RESULTS: The levels of etiocholanolone (E) (p < 0.05), beta-cortolone (beta-CL) (p < 0.01) were significantly decreased, while levels of allo-tetrahydrocorticosterone (aTHB) (p < 0.05) and cortisol (F) (p < 0.01) were elevated in depressed women. The levels of dehydroepiandrosterone (DHEA) (p < 0.01), tetrahydrocorticosterone (THB) (p < 0.01), beta-CL (p < 0.01), and aTHB (p < 0.05) were found significantly decreased in depressed men. The index of 11beta-HSD activity (p < 0.01) was significantly decreased in patients in both sexes. LIMITATIONS: The sample is limited to only urine samples of patient with URMD; the correlation between the severity of depression and F and DHEA was not analyzed.
CONCLUSION: Our investigations confirmed that URMD associated with altered steroid metabolism, which shows gender differences, pointing to the different stress sensibility of women. These differences may be the cause as well as the consequence of the major depression (MD).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15183600     DOI: 10.1016/S0165-0327(03)00199-X

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  14 in total

Review 1.  Disruption of fetal hormonal programming (prenatal stress) implicates shared risk for sex differences in depression and cardiovascular disease.

Authors:  J M Goldstein; R J Handa; S A Tobet
Journal:  Front Neuroendocrinol       Date:  2013-12-16       Impact factor: 8.606

Review 2.  Structure-activity relationship studies on neuroactive steroids in memory, alcohol and stress-related functions: a crucial benefit from endogenous level analysis.

Authors:  Monique Vallée
Journal:  Psychopharmacology (Berl)       Date:  2014-04-30       Impact factor: 4.530

3.  Anticonvulsant activity of androsterone and etiocholanolone.

Authors:  Rafal M Kaminski; Herbert Marini; Won-Joo Kim; Michael A Rogawski
Journal:  Epilepsia       Date:  2005-06       Impact factor: 5.864

Review 4.  The relevance of neuroactive steroids in schizophrenia, depression, and anxiety disorders.

Authors:  Erin M MacKenzie; John Odontiadis; Jean-Michel Le Mellédo; Trevor I Prior; Glen B I Baker
Journal:  Cell Mol Neurobiol       Date:  2007-08       Impact factor: 5.046

Review 5.  Glucocorticoid dysregulations and their clinical correlates. From receptors to therapeutics.

Authors:  Andrea H Marques; Marni N Silverman; Esther M Sternberg
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

6.  Dose response and time course studies on superoxide dismutase as a urinary biomarker of carbon tetrachloride-induced hepatic injury in the Hanover Wistar rat.

Authors:  Rosemary Smyth; Michael R Munday; Malcolm J York; Christopher J Clarke; Theo Dare; John A Turton
Journal:  Int J Exp Pathol       Date:  2009-10       Impact factor: 1.925

Review 7.  Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS).

Authors:  Nicole Maninger; Owen M Wolkowitz; Victor I Reus; Elissa S Epel; Synthia H Mellon
Journal:  Front Neuroendocrinol       Date:  2008-12-03       Impact factor: 8.606

Review 8.  Prenatal excess glucocorticoid exposure and adult affective disorders: a role for serotonergic and catecholamine pathways.

Authors:  Caitlin S Wyrwoll; Megan C Holmes
Journal:  Neuroendocrinology       Date:  2011-10-25       Impact factor: 4.914

Review 9.  Depression and obesity: evidence of shared biological mechanisms.

Authors:  Yuri Milaneschi; W Kyle Simmons; Elisabeth F C van Rossum; Brenda Wjh Penninx
Journal:  Mol Psychiatry       Date:  2018-02-16       Impact factor: 15.992

10.  Early response to venlafaxine antidepressant correlates with lower ACTH levels prior to pharmacological treatment.

Authors:  A V Araya; P Rojas; R Fritsch; R Rojas; L Herrera; G Rojas; H Gatica; H Silva; J L Fiedler
Journal:  Endocrine       Date:  2006-12       Impact factor: 3.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.